{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:47:49Z","timestamp":1794541669836,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Haemophilic arthropathy is a chronic and debilitating joint disease caused by recurrent spontaneous joint bleeds in patients with haemophilia. Understanding how characteristics of individual joint bleeds relate to the subsequent development of arthropathy could improve management and prevention of this joint disease. Here, we aimed to explore relations between joint bleed characteristics and development of bone pathology in a mouse model of haemophilic arthropathy by using novel in vivo imaging methodology.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We characterised induced knee bleeds in a murine model of haemophilic arthropathy by quantitative in vivo fluorescence molecular tomography (FMT) and by measurements of changes in the diameter of the injured knee. Wild-type mice and non-injured haemophilic mice acted as controls. Development of arthropathy was characterised by post mortem evaluation of bone pathology by micro-CT 14\u2009days after bleed-induction. In an in vitro study, we assessed the effect of blood on the quantification of fluorescent signal with FMT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In most injured haemophilic mice, we observed significant loss of trabecular bone, and half of the mice developed pathological bone remodelling. Development of pathological bone remodelling was associated with significantly increased fluorescent signal and diameter of the injured knee just 1 day after induction of the bleed. Further, a correlation between the fluorescent signal 1 day after induction of the bleed and loss of trabecular bone reached borderline significance. In the in vitro study, we found that high concentrations of blood significantly decreased the fluorescent signal.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our results add novel insights on the pathogenesis of haemophilic arthropathy and underline the importance of the acute phase of joint bleeds for the subsequent development of arthropathy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-020-03267-5","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T16:02:56Z","timestamp":1586880176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["In vivo fluorescence molecular tomography of induced haemarthrosis in haemophilic mice: link between bleeding characteristics and development of bone pathology"],"prefix":"10.1186","volume":"21","author":[{"given":"K. K.","family":"V\u00f8ls","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kjelgaard-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. D.","family":"Ley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. K.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,14]]},"reference":[{"issue":"23","key":"3267_CR1","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1056\/NEJM200106073442307","volume":"344","author":"PM Mannucci","year":"2001","unstructured":"Mannucci PM, Tuddenham EG. The hemophilias--from royal genes to gene therapy. N Engl J Med. 2001;344(23):1773\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"3267_CR2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/j.1365-2516.2012.02909.x","volume":"19","author":"A Srivastava","year":"2013","unstructured":"Srivastava A, et al. Guidelines for the management of hemophilia. Haemophilia. 2013;19(1):e1\u201347.","journal-title":"Haemophilia"},{"issue":"Suppl 4","key":"3267_CR3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1365-2516.2004.00976.x","volume":"10","author":"K Mulder","year":"2004","unstructured":"Mulder K, Llin\u00e1s A. The target joint. Haemophilia. 2004;10(Suppl 4):152\u20136.","journal-title":"Haemophilia"},{"issue":"8","key":"3267_CR4","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1136\/ard.50.8.588","volume":"50","author":"R Madhok","year":"1991","unstructured":"Madhok R, York J, Sturrock RD. Haemophilic arthritis. Ann Rheum Dis. 1991;50(8):588\u201391.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"3267_CR5","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/ajh.24133","volume":"90","author":"V Bhat","year":"2015","unstructured":"Bhat V, et al. Vascular remodeling underlies rebleeding in hemophilic arthropathy. Am J Hematol. 2015;90(11):1027\u201335.","journal-title":"Am J Hematol"},{"issue":"5","key":"3267_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/micc.12273","volume":"23","author":"W Kidder","year":"2016","unstructured":"Kidder W, et al. Persistent vascular remodeling and leakiness are important components of the pathobiology of re-bleeding in hemophilic joints: two informative cases. Microcirculation. 2016;23(5):373\u20138.","journal-title":"Microcirculation"},{"issue":"2","key":"3267_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1600-0609.2012.01803.x","volume":"89","author":"K Ghosh","year":"2012","unstructured":"Ghosh K, Shetty S. Bone health in persons with haemophilia: a review. Eur J Haematol. 2012;89(2):95\u2013102.","journal-title":"Eur J Haematol"},{"issue":"5","key":"3267_CR8","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1365-2141.2008.07386.x","volume":"143","author":"NW Jansen","year":"2008","unstructured":"Jansen NW, Roosendaal G, Lafeber FP. Understanding haemophilic arthropathy: an exploration of current open issues. Br J Haematol. 2008;143(5):632\u201340.","journal-title":"Br J Haematol"},{"issue":"6","key":"3267_CR9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1365-2141.2007.06490.x","volume":"136","author":"L Raffini","year":"2007","unstructured":"Raffini L, Manno C. Modern management of haemophilic arthropathy. Br J Haematol. 2007;136(6):777\u201387.","journal-title":"Br J Haematol"},{"issue":"5","key":"3267_CR10","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1034\/j.1600-0455.2002.430514.x","volume":"43","author":"K Fischer","year":"2002","unstructured":"Fischer K, et al. Association between joint bleeds and Pettersson scores in severe haemophilia. Acta Radiol. 2002;43(5):528\u201332.","journal-title":"Acta Radiol"},{"issue":"4","key":"3267_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1365-2796.1994.tb00815.x","volume":"236","author":"LM Aledort","year":"1994","unstructured":"Aledort LM, Haschmeyer RH, Pettersson H. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic outcome study group. J Intern Med. 1994;236(4):391\u20139.","journal-title":"J Intern Med"},{"issue":"6","key":"3267_CR12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1056\/NEJMoa067659","volume":"357","author":"MJ Manco-Johnson","year":"2007","unstructured":"Manco-Johnson MJ, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357(6):535\u201344.","journal-title":"N Engl J Med"},{"issue":"2","key":"3267_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/ajh.2830470209","volume":"47","author":"MJ Manco-Johnson","year":"1994","unstructured":"Manco-Johnson MJ, et al. Results of secondary prophylaxis in children with severe hemophilia. Am J Hematol. 1994;47(2):113\u20137.","journal-title":"Am J Hematol"},{"issue":"4","key":"3267_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/hae.13236","volume":"23","author":"LFD van Vulpen","year":"2017","unstructured":"van Vulpen LFD, et al. Differential effects of bleeds on the development of arthropathy - basic and applied issues. Haemophilia. 2017;23(4):521\u20137..","journal-title":"Haemophilia"},{"issue":"2","key":"3267_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1365-2516.2007.01636.x","volume":"14","author":"K \u00d8vlisen","year":"2008","unstructured":"\u00d8vlisen K, Kristensen AT, Tranholm M. In vivo models of haemophilia - status on current knowledge of clinical phenotypes and therapeutic interventions. Haemophilia. 2008;14(2):248\u201359.","journal-title":"Haemophilia"},{"issue":"3","key":"3267_CR16","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1365-2516.2004.00899.x","volume":"10","author":"LA Valentino","year":"2004","unstructured":"Valentino LA, et al. Experimental haemophilic synovitis: rationale and development of a murine model of human factor VIII deficiency. Haemophilia. 2004;10(3):280\u20137.","journal-title":"Haemophilia"},{"issue":"6","key":"3267_CR17","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1055\/s-0038-1641755","volume":"118","author":"EJ Cooke","year":"2018","unstructured":"Cooke EJ, et al. Vascular permeability and Remodelling coincide with inflammatory and reparative processes after joint bleeding in factor VIII-deficient mice. Thromb Haemost. 2018;118(6):1036\u201347.","journal-title":"Thromb Haemost"},{"issue":"1","key":"3267_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/hae.13080","volume":"23","author":"KR Christensen","year":"2016","unstructured":"Christensen KR, et al. Visualization of haemophilic arthropathy in F8(\u2212\/\u2212) rats by ultrasonography and micro-computed tomography. Haemophilia. 2016;23(1):152\u201362.","journal-title":"Haemophilia"},{"issue":"2","key":"3267_CR19","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/hae.13672","volume":"25","author":"KK V\u00f8ls","year":"2019","unstructured":"V\u00f8ls KK, et al. Bleed volume of experimental knee haemarthrosis correlates with the subsequent degree of haemophilic arthropathy. Haemophilia. 2019;25(2):324\u201333.","journal-title":"Haemophilia"},{"issue":"8","key":"3267_CR20","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1093\/rheumatology\/keq012","volume":"49","author":"LL Gompels","year":"2010","unstructured":"Gompels LL, et al. In vivo optical imaging in arthritis--an enlightening future? Rheumatology (Oxford). 2010;49(8):1436\u201346.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"3267_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3109\/03008207.2015.1012586","volume":"56","author":"MD Slooter","year":"2015","unstructured":"Slooter MD, et al. Near infrared fluorescence imaging for early detection, monitoring and improved intervention of diseases involving the joint. Connect Tissue Res. 2015;56(2):153\u201360.","journal-title":"Connect Tissue Res"},{"issue":"3","key":"3267_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nbt1074","volume":"23","author":"V Ntziachristos","year":"2005","unstructured":"Ntziachristos V, et al. Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol. 2005;23(3):313\u201320.","journal-title":"Nat Biotechnol"},{"key":"3267_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.bioeng.8.061505.095831","volume":"8","author":"V Ntziachristos","year":"2006","unstructured":"Ntziachristos V. Fluorescence molecular imaging. Annu Rev Biomed Eng. 2006;8:1\u201333.","journal-title":"Annu Rev Biomed Eng"},{"issue":"9","key":"3267_CR24","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/jbio.201600232","volume":"10","author":"S Rosenhain","year":"2017","unstructured":"Rosenhain S, et al. Sensitivity and accuracy of hybrid fluorescence-mediated tomography in deep tissue regions. J Biophotonics. 2017;10(9):1208\u201316.","journal-title":"J Biophotonics"},{"issue":"3","key":"3267_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/0023677214524381","volume":"48","author":"M Groth","year":"2014","unstructured":"Groth M, et al. Buprenorphine does not impact the inflammatory response in haemophilia a mice with experimentally-induced haemarthrosis. Lab Anim. 2014;48(3):225\u201336.","journal-title":"Lab Anim"},{"issue":"3","key":"3267_CR26","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1148\/radiol.2423052065","volume":"242","author":"X Montet","year":"2007","unstructured":"Montet X, et al. Tomographic fluorescence imaging of tumor vascular volume in mice. Radiology. 2007;242(3):751\u20138.","journal-title":"Radiology"},{"issue":"1","key":"3267_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/hae.12532","volume":"21","author":"LA Valentino","year":"2015","unstructured":"Valentino LA, et al. The biological efficacy profile of BAX 855, a PEGylated recombinant factor VIII molecule. Haemophilia. 2015;21(1):58\u201363.","journal-title":"Haemophilia"},{"issue":"5","key":"3267_CR28","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/hae.12399","volume":"20","author":"AG Lau","year":"2014","unstructured":"Lau AG, et al. Joint bleeding in factor VIII deficient mice causes an acute loss of trabecular bone and calcification of joint soft tissues which is prevented with aggressive factor replacement. Haemophilia. 2014;20(5):716\u201322.","journal-title":"Haemophilia"},{"issue":"7","key":"3267_CR29","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.crad.2010.03.011","volume":"65","author":"MA Pysz","year":"2010","unstructured":"Pysz MA, Gambhir SS, Willmann JK. Molecular imaging: current status and emerging strategies. Clin Radiol. 2010;65(7):500\u201316.","journal-title":"Clin Radiol"},{"issue":"3","key":"3267_CR30","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1152\/japplphysiol.00959.2007","volume":"104","author":"J Haller","year":"2008","unstructured":"Haller J, et al. Visualization of pulmonary inflammation using noninvasive fluorescence molecular imaging. J Appl Physiol (1985). 2008;104(3):795\u2013802.","journal-title":"J Appl Physiol (1985)"},{"key":"3267_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.bb.20.060191.000245","volume":"20","author":"B Chance","year":"1991","unstructured":"Chance B. Optical method. Annu Rev Biophys Biophys Chem. 1991;20:1\u201328.","journal-title":"Annu Rev Biophys Biophys Chem"},{"issue":"5","key":"3267_CR32","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.cbpa.2003.08.007","volume":"7","author":"JV Frangioni","year":"2003","unstructured":"Frangioni JV. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol. 2003;7(5):626\u201334.","journal-title":"Curr Opin Chem Biol"},{"issue":"1","key":"3267_CR33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10456-013-9391-4","volume":"17","author":"T Persigehl","year":"2014","unstructured":"Persigehl T, et al. Non-invasive monitoring of tumor-vessel infarction by retargeted truncated tissue factor tTF-NGR using multi-modal imaging. Angiogenesis. 2014;17(1):235\u201346.","journal-title":"Angiogenesis"},{"issue":"10","key":"3267_CR34","doi-asserted-by":"publisher","first-page":"960","DOI":"10.7150\/thno.9293","volume":"4","author":"F Gremse","year":"2014","unstructured":"Gremse F, et al. Absorption reconstruction improves biodistribution assessment of fluorescent nanoprobes using hybrid fluorescence-mediated tomography. Theranostics. 2014;4(10):960\u201371.","journal-title":"Theranostics"},{"issue":"7","key":"3267_CR35","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nm729","volume":"8","author":"V Ntziachristos","year":"2002","unstructured":"Ntziachristos V, et al. Fluorescence molecular tomography resolves protease activity in vivo. Nat Med. 2002;8(7):757\u201360.","journal-title":"Nat Med"},{"issue":"1","key":"3267_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12185-019-02639-5","volume":"110","author":"P He","year":"2019","unstructured":"He P, et al. Timely and large dose of clotting factor IX provides better joint wound healing after hemarthrosis in hemophilia B mice. Int J Hematol. 2019;110(1):59\u201368.","journal-title":"Int J Hematol"},{"issue":"6\u20137","key":"3267_CR37","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.biocel.2007.12.003","volume":"40","author":"EJ Mackie","year":"2008","unstructured":"Mackie EJ, et al. Protease-activated receptors in the musculoskeletal system. Int J Biochem Cell Biol. 2008;40(6\u20137):1169\u201384.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"3267_CR38","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/rheumatology\/key186","volume":"58","author":"KR Christensen","year":"2019","unstructured":"Christensen KR, et al. Rapid inflammation and early degeneration of bone and cartilage revealed in a time-course study of induced haemarthrosis in haemophilic rats. Rheumatology (Oxford). 2019;58(4):588\u201399.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"3267_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-2516.2006.01405.x","volume":"13","author":"TA Wallny","year":"2007","unstructured":"Wallny TA, et al. Osteoporosis in haemophilia - an underestimated comorbidity? Haemophilia. 2007;13(1):79\u201384.","journal-title":"Haemophilia"},{"issue":"2","key":"3267_CR40","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1365-2516.2008.01963.x","volume":"15","author":"G Gerstner","year":"2009","unstructured":"Gerstner G, et al. Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia. Haemophilia. 2009;15(2):559\u201365.","journal-title":"Haemophilia"},{"issue":"10","key":"3267_CR41","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1182\/blood-2017-12-820571","volume":"132","author":"C Haxaire","year":"2018","unstructured":"Haxaire C, et al. Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2\/ADAM17\/TNF-\u03b1 pathway. Blood. 2018;132(10):1064\u201374.","journal-title":"Blood"},{"issue":"7","key":"3267_CR42","doi-asserted-by":"publisher","first-page":"4858","DOI":"10.1074\/jbc.275.7.4858","volume":"275","author":"Y Azuma","year":"2000","unstructured":"Azuma Y, et al. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem. 2000;275(7):4858\u201364.","journal-title":"J Biol Chem"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-020-03267-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-020-03267-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-020-03267-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T23:26:59Z","timestamp":1618356419000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-020-03267-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,14]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3267"],"URL":"https:\/\/doi.org\/10.1186\/s12891-020-03267-5","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,14]]},"assertion":[{"value":"25 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal studies were conducted according to the EU Directive 2010\/63\/EU and the Danish Animal Experimentation Act and were approved by the Danish Animal Experiments Council, the Danish Ministry of Environment and Food, as well as the Novo Nordisk Animal Welfare Body.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CD Ley and M Petersen are employed by Novo Nordisk A\/S. M Kjelgaard-Hansen was employed by Novo Nordisk A\/S during the study. CD Ley, M Petersen, and KK V\u00f8ls are shareholders of Novo Nordisk A\/S. KK V\u00f8ls reports grants from the University of Copenhagen and Novo Nordisk A\/S during the study. AK Hansen has nothing to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"241"}}